Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
2.540
0.00 (0.00%)
At close: Aug 28, 2026, 4:00 PM EDT
2.440
-0.100 (-3.94%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$18,026
Profits / Employee
-$1,490,638
Market Cap
4.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 33 |
| Calidi Biotherapeutics | 29 |
| VivoSim Labs | 15 |
| Revelation Biosciences | 9 |
| Jupiter Neurosciences | 5 |
| Mustang Bio | 4 |
| GRI Bio | 4 |
| SciSparc | 3 |
SILO News
- 11 days ago - Silo Pharma receives notice of allowance from CIPO for PTSD treatment - TheFly
- 11 days ago - Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - GlobeNewsWire
- 19 days ago - Silo Pharma granted European patent covering PTSD therapy - TheFly
- 23 days ago - Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - GlobeNewsWire
- 5 weeks ago - Silo Pharma files to sell 1.91M shares of common stock for holders - TheFly
- 5 weeks ago - Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program - GlobeNewsWire
- 6 weeks ago - Silo Pharma subsidiary QwikAgents joins AMD AI program - TheFly
- 6 weeks ago - Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform - GlobeNewsWire